Clinical Trial Update: Purinergic Signaling and the Postmenopausal Heart

View source ↗

Summary

A clinical trial evaluating purinergic signaling in postmenopausal heart function is currently recruiting. The study targets heart failure with preserved ejecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Diastolic Heart Failure, Heart Failure With Preserved Ejection Fraction | Status: RECRUITING